Herrmann, Ken http://orcid.org/0000-0002-9662-7259
Giovanella, Luca
Santos, Andrea
Gear, Jonathan
Kiratli, Pinar Ozgen
Kurth, Jens
Denis-Bacelar, Ana M.
Hustinx, Roland
Patt, Marianne
Wahl, Richard L.
Paez, Diana
Giammarile, Francesco
Jadvar, Hossein
Pandit-Taskar, Neeta
Ghesani, Munir
Kunikowska, Jolanta
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 15 March 2022
Accepted: 25 March 2022
First Online: 11 April 2022
Declarations
:
: This manuscript does not contain proprietary human data; accordingly an informed consent is not applicable.
: KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, all outside the submitted work. LG reports personal fees from Roche Diagnostics and SNIBE for advisory board participation, and research support from Roche Diagnostics., all outside the submitted work. AMDB is supported by the National Measurement System of the UK Department for Business, Energy and Industrial Strategy. RLW has research contracts from Siemens, Bayer, Actinium Pharmaceuticals, and serves (with compensation) on the scientific advisory boards of Seno Medical and Clarity Pharmaceuticals. HJ serves on the advisory board of Radiomedix, is a consultant to Bayer and Blue Earth Diagnostics, an investigator for ImaginAb, and on the speaker's bureau of Lantheus. MG reports fee for speakers bureau of Novartis, Blue Earth and Ionetix (not active currently). The remaining authors have no relevant conflict of interest to declare with regards to this comment.
: This manuscript does not contain proprietary research involving neither humans nor animals.
: This guideline summarizes the views of the co-authoring EANM Committee members, SNMMI representatives and IAEA co-authors. It reflects recommendations for which the EANM, the SNMMI and the IAEA cannot be held responsible. The recommendations should be taken into the context of good practice of nuclear medicine and do not substitute for national and international legal or regulatory provisions.